Close

Articles Posted in Product Liability

Updated:

Woman files HRT suit in Marshall Texas

MARSHALL TEXAS– California resident Canstanza Raspa claims that her development of breast cancer, resulting surgery and mastectomy are the result of 10 years of hormone replacement therapy. Raspa filed a product liability suit against hormone replacement manufacturers Wyeth, Pfizer, Pharmacia and Upjohn Inc. on Sept 3, in the Marshall Division…

Updated:

Avandia Lawsuits

Diabetes patients who use the drug Avandia face an increased risk of serious and potentially fatal injuries of heart attack, stroke, congestive heart failure, bone fractures or death. Federal lawsuits have been consolidated in an MDL (Multi-District Litigation) in the Eastern District of Pennsylvania. Avandia is a type 2 diabetes…

Updated:

Lilly, Amylin Disclose More Cases of Byetta-Related Pancreatitis

Last week, the FDA said it had received reports of six new cases of pancreatitis – including two deaths – associated with the diabetes drug Byetta. Today, Amylin and Eli Lilly said that they had reported four additional deaths to the agency as well, which the FDA hasn’t yet made…

Updated:

FDA Receives 2 Reports of Death, 4 More Hospitalizations in Patients Using Type 2 Diabetes Drug Byetta

The FDA today said it plans to strengthen warnings about life-threatening pancreas problems linked to the type 2 diabetes drug Byetta after getting two reports of deaths and four other hospitalizations in Byetta users. Those patients had hemorrhagic pancreatitis (inflammation of the pancreas with bleeding) or necrotizing pancreatitis (in which…

Updated:

FDA and Byetta Pancreatitis Side Effects

Byetta is an injectable therapy to improve blood sugar control in patients with Type II diabetes, which is most often prescribed for patients who have not been able to achieve adequate control on metformin and/or a sulfonylurea, two often prescribed diabetes medications that are taken orally. Byetta has been prescribed…

Updated:

Defective Drugs: Digitek Lawsuits

Two months after a Digitek recall was issued due to manufacturing problems that allowed double strength tablets to be commercially released, at least three lawsuits have been filed. A number of additional cases are expected to be filed in the coming weeks, as hundreds of potential cases are currently being…

Contact Us
Start Chat